Scribe Therapeutics
Scribe Therapeutics's email is bd@scribetx.com
.
Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR. The company’s first technology, called X-Editing (XE) molecules, are highly engineered CRISPR enzymes that provide combined aspects of greater efficacy, specificity, and deliverability than currently available CRISPR genome editing technology. It also a long-term, engineering approach that can help establish CRISPR-based therapies as a new standard of clinical care and expand access to groundbreaking treatments that will impact millions of lives. Scribe Therapeutics is ...
read more
Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR. The company’s first technology, called X-Editing (XE) molecules, are highly engineered CRISPR enzymes that provide combined aspects of greater efficacy, specificity, and deliverability than currently available CRISPR genome editing technology. It also a long-term, engineering approach that can help establish CRISPR-based therapies as a new standard of clinical care and expand access to groundbreaking treatments that will impact millions of lives. Scribe Therapeutics is overcoming the limitations of current genome editing technologies by developing custom-engineered enzymes and delivery modalities as part of a proprietary, evergreen platform for CRISPR-based genetic medicine. The company built for exceptional specificity within the genome – enabling therapeutic precision and allele-specific targeting. Scribe Therapeutics was founded in 2018 and is headquartered in Alameda, CA, USA.
show less
Website | scribetx.com | |
Industry | Biotechnology | |
Location | Alameda, California, United States | |
Employees | 18 |
HQ | 1150 Marina Village Pkwy | |
bd@scribetx.com | ||
Funding | 120,000,000 USD | |
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
Website | scribetx.com | |
Industry | Biotechnology | |
Location | Alameda, California, United States | |
Employees | 18 | |
linkedin.com/company/scribe-therapeutics | ||
HQ | 1150 Marina Village Pkwy | |
bd@scribetx.com | ||
Funding | 120,000,000 USD |
Email Patterns for Scribe Therapeutics
Top Competitors for Scribe Therapeutics
Scribe Therapeutics Questions
Where are Scribe Therapeutics's headquarters?
Scribe Therapeutics's headquarters are in 1150 Marina Village Pkwy
What is Scribe Therapeutics's official website?
Scribe Therapeutics's website is scribetx.com
How many employees are working in Scribe Therapeutics right now?
Scribe Therapeutics has
18 employees.
View the Email and Phone Numbers for all 18 working at Scribe Therapeutics.
What is Scribe Therapeutics's industry?
Scribe Therapeutics's industry is
Biotechnology
Who are Scribe Therapeutics's top competitors?
Scribe Therapeutics's top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What is Scribe Therapeutics's email address?
Scribe Therapeutics's email address is bd@scribetx.com
What are Scribe Therapeutics's categories?
Scribe Therapeutics's categories are Biotechnology, Life Science, Therapeutics
What is Scribe Therapeutics's location?
Scribe Therapeutics's location is
Alameda, California, United States
What is Scribe Therapeutics's funding?
Scribe Therapeutics's funding is 120,000,000 USD
What is Scribe Therapeutics's current status?
Scribe Therapeutics's current status is operating
Top Scribe Therapeutics Employees
Senior Manager, Strategy And Operations
iaanei@lbl.gov
+1510-541-7780
Chief Business Officer
lucas@xoma.com
+1650-383-0800
Scientist
ok37@cornell.edu
+1212-327-7490
Scientist
benjamindemaree@gmail.com
+1503-310-7230
Research Specialist
j.amerasekera@berkeley.edu
+1972-415-4722
Scientist
smakhija@berkeley.edu
+1510-642-3383
Chief Executive Officer
benjamin.oakes@gmail.com
+1812-568-6085